Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Henrick, K.
Right arrow Articles by Hughes, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henrick, K.
Right arrow Articles by Hughes, R. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 8, 45-57, Copyright © 1998 by Society for Glycobiology

ORIGINAL ARTICLES

Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3

K Henrick, S Bawumia, EA Barboni, B Mehul and RC Hughes
National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom.

A model of the carbohydrate recognition domain CRD, residues 111-245, of hamster galectin-3 has been made using homology modeling and dynamics minimization methods. The model is based on the known x-ray structures of bovine galectin-1 and human galectin-2. The oligosaccharides NeuNAc-alpha2,3-Gal-beta1,4-Glc and GalNAc-alpha1, 3- [Fuc-alpha1,2]-Gal-beta1,4-Glc, known to be specific high-affinity ligands for galectin-3, as well as lactose recognized by all galectins were docked in the galectin-3 CRD model structure and a minimized binding conformation found in each case. These studies indicate a putative extended carbohydrate-binding subsite in the hamster galectin- 3 involving Arg139, Glu230, and Ser232 for NeuNAc-alpha2,3-; Arg139 and Glu160 for fucose-alpha1,2-; and Arg139 and Ile141 for GalNAc-alpha1,3- substituents on the primary galactose. Each of these positions is variable within the whole galectin family. Two of these residues, Arg139 and Ser232, were selected for mutagenesis to probe their importance in this newly identified putative subsite. Residue 139 adopts main-chain dihedral angles characteristic of an isolated bridge structural feature, while residue 232 is the C-terminal residue of beta- strand-11, and is followed immediately by an inverse gamma-turn. A systematic series of mutant proteins have been prepared to represent the residue variation present in the aligned sequences of galectins-1, - 2, and -3. Minimized docked models were generated for each mutant in complex with NeuNAc-alpha2,3-Gal-beta1,4-Glc, GalNAc-alpha1, 3-[Fuc- alpha1,2]-Gal-beta1,4- Glc, and Gal-beta1,4-Glc. Correlation of the computed protein-carbohydrate interaction energies for each lectin- oligosaccharide pair with the experimentally determined binding affinities for fetuin and asialofetuin or the relative potencies of lactose and sialyllactose in inhibiting binding to asiolofetuin is consistent with the postulated key importance of Arg139 in recognition of the extended sialylated ligand.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Ideo, A. Seko, and K. Yamashita
Recognition Mechanism of Galectin-4 for Cholesterol 3-Sulfate
J. Biol. Chem., July 20, 2007; 282(29): 21081 - 21089.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Demers, K. Biron-Pain, J. Hebert, A. Lamarre, T. Magnaldo, and Y. St-Pierre
Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model
Cancer Res., March 15, 2007; 67(6): 2824 - 2829.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. G. Chiu, T. M. Johnson, A. S. Woolf, E. M. Dahm-Vicker, D. A. Long, L. Guay-Woodford, K. A. Hillman, S. Bawumia, K. Venner, R. C. Hughes, et al.
Galectin-3 Associates with the Primary Cilium and Modulates Cyst Growth in Congenital Polycystic Kidney Disease
Am. J. Pathol., December 1, 2006; 169(6): 1925 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
H. Stalz, U. Roth, D. Schleuder, M. Macht, S. Haebel, K. Strupat, J. Peter-Katalinic, and F.-G. Hanisch
The Geodia cydonium galectin exhibits prototype and chimera-type characteristics and a unique sequence polymorphism within its carbohydrate recognition domain
Glycobiology, May 1, 2006; 16(5): 402 - 414.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Lagana, J. G. Goetz, P. Cheung, A. Raz, J. W. Dennis, and I. R. Nabi
Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor Cells
Mol. Cell. Biol., April 15, 2006; 26(8): 3181 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. K. van den Berg, H. Honing, N. Franke, A. van Remoortere, W. E. C. M. Schiphorst, F.-T. Liu, A. M. Deelder, R. D. Cummings, C. H. Hokke, and I. van Die
LacdiNAc-Glycans Constitute a Parasite Pattern for Galectin-3-Mediated Immune Recognition
J. Immunol., August 1, 2004; 173(3): 1902 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Pelletier, T. Hashidate, T. Urashima, N. Nishi, T. Nakamura, M. Futai, Y. Arata, K.-i. Kasai, M. Hirashima, J. Hirabayashi, et al.
Specific Recognition of Leishmania major Poly-{beta}-galactosyl Epitopes by Galectin-9: POSSIBLE IMPLICATION OF GALECTIN-9 IN INTERACTION BETWEEN L. MAJOR AND HOST CELLS
J. Biol. Chem., June 13, 2003; 278(25): 22223 - 22230.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
S. Sassi, M. Sweetinburgh, J. Erogul, P. Zhang, P. Teng-umnuay, and C. M. West
Analysis of Skp1 glycosylation and nuclear enrichment in Dictyostelium
Glycobiology, April 1, 2001; 11(4): 283 - 295.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. L. BULLOCK, T. M. JOHNSON, Q. BAO, R. C. HUGHES, P. J. D. WINYARD, and A. S. WOOLF
Galectin-3 Modulates Ureteric Bud Branching in Organ Culture of the Developing Mouse Kidney
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 515 - 523.
[Abstract] [Full Text]

Home page
 GlycobiologyHome page
E. A. M. Barboni, S. Bawumia, K. Henrick, and R.C. Hughes
Molecular modeling and mutagenesis studies of the N-terminal domains of galectin-3: evidence for participation with the C-terminal carbohydrate recognition domain in oligosaccharide binding
Glycobiology, November 1, 2000; 10(11): 1201 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Fradin, D. Poulain, and T. Jouault
beta -1,2-Linked Oligomannosides from Candida albicans Bind to a 32-Kilodalton Macrophage Membrane Protein Homologous to the Mammalian Lectin Galectin-3
Infect. Immun., August 1, 2000; 68(8): 4391 - 4398.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Kleene, H. Yang, M. Kutsche, and M. Schachner
The Neural Recognition Molecule L1 Is a Sialic Acid-binding Lectin for CD24, Which Induces Promotion and Inhibition of Neurite Outgrowth
J. Biol. Chem., June 8, 2001; 276(24): 21656 - 21663.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.